Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy

Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction

Pere Puigserver, James Rhee, Jerry Donovan et al. · Nature · 2003 · 1.5K citations

Life Sciences, Endocrinology, Molecular Biology +14

Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY

Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay et al. · Endocrine Practice · 2016 · 875 citations

Medicine, Endocrinology, Internal Medicine +15

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay et al. · Endocrine Practice · 2018 · 505 citations

Medicine, Endocrinology, Internal Medicine +15

Empagliflozin as Add-On to Metformin in Patients With Type 2 Diabetes: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Trial

Hans‐Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker et al. · Diabetes Care · 2014 · 393 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo

Anila K. Madiraju, Yang Qiu, Rachel J. Perry et al. · Nature Medicine · 2018 · 307 citations · Full text

Life Sciences, Endocrinology, Pharmacology +12